VistaGen Therapeutics Stock Forward View - Relative Strength Index
| VTGN Stock | USD 0.56 0.05 9.80% |
VistaGen Stock outlook is based on your current time horizon. Although VistaGen Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of VistaGen Therapeutics' systematic risk associated with finding meaningful patterns of VistaGen Therapeutics fundamentals over time.
As of today the rsi of VistaGen Therapeutics' share price is below 20 . This entails that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.32) | EPS Estimate Current Year (1.83) | EPS Estimate Next Year (1.23) | Wall Street Target Price 0.9667 | EPS Estimate Current Quarter (0.44) |
Using VistaGen Therapeutics hype-based prediction, you can estimate the value of VistaGen Therapeutics from the perspective of VistaGen Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards VistaGen Therapeutics using VistaGen Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards VistaGen using crowd psychology based on the activity and movement of VistaGen Therapeutics' stock price.
VistaGen Therapeutics Short Interest
An investor who is long VistaGen Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about VistaGen Therapeutics and may potentially protect profits, hedge VistaGen Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 2.7481 | Short Percent 0.0883 | Short Ratio 0.41 | Shares Short Prior Month 3.4 M | 50 Day MA 1.9246 |
VistaGen Relative Strength Index
VistaGen Therapeutics Hype to Price Pattern
Investor biases related to VistaGen Therapeutics' public news can be used to forecast risks associated with an investment in VistaGen. The trend in average sentiment can be used to explain how an investor holding VistaGen can time the market purely based on public headlines and social activities around VistaGen Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of VistaGen Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about VistaGen Therapeutics.
VistaGen Therapeutics Implied Volatility | 2.05 |
VistaGen Therapeutics' implied volatility exposes the market's sentiment of VistaGen Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if VistaGen Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that VistaGen Therapeutics stock will not fluctuate a lot when VistaGen Therapeutics' options are near their expiration.
VistaGen Therapeutics after-hype prediction price | USD 0.53 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of VistaGen Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current VistaGen contract
Based on the Rule 16, the options market is currently suggesting that VistaGen Therapeutics will have an average daily up or down price movement of about 0.13% per day over the life of the 2026-05-15 option contract. With VistaGen Therapeutics trading at USD 0.56, that is roughly USD 7.17E-4 . If you think that the market is fully incorporating VistaGen Therapeutics' daily price movement you should consider acquiring VistaGen Therapeutics options at the current volatility level of 2.05%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 VistaGen Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast VistaGen Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in VistaGen Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for VistaGen Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current VistaGen Therapeutics' open interest, investors have to compare it to VistaGen Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of VistaGen Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in VistaGen. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
VistaGen Therapeutics Additional Predictive Modules
Most predictive techniques to examine VistaGen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for VistaGen using various technical indicators. When you analyze VistaGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check VistaGen Therapeutics Volatility | Backtest VistaGen Therapeutics | Information Ratio |
VistaGen Therapeutics Trading Date Momentum
| On February 06 2026 VistaGen Therapeutics was traded for 0.56 at the closing time. The top price for the day was 0.57 and the lowest listed price was 0.50 . The trading volume for the day was 1.7 M. The trading history from February 6, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 8.93% . |
| Compare VistaGen Therapeutics to competition |
Other Forecasting Options for VistaGen Therapeutics
For every potential investor in VistaGen, whether a beginner or expert, VistaGen Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. VistaGen Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in VistaGen. Basic forecasting techniques help filter out the noise by identifying VistaGen Therapeutics' price trends.VistaGen Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VistaGen Therapeutics stock to make a market-neutral strategy. Peer analysis of VistaGen Therapeutics could also be used in its relative valuation, which is a method of valuing VistaGen Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
VistaGen Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how VistaGen Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VistaGen Therapeutics shares will generate the highest return on investment. By undertsting and applying VistaGen Therapeutics stock market strength indicators, traders can identify VistaGen Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 211970.0 | |||
| Daily Balance Of Power | 0.7143 | |||
| Rate Of Daily Change | 1.1 | |||
| Day Median Price | 0.53 | |||
| Day Typical Price | 0.54 | |||
| Price Action Indicator | 0.05 | |||
| Period Momentum Indicator | 0.05 |
VistaGen Therapeutics Risk Indicators
The analysis of VistaGen Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in VistaGen Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vistagen stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.62 | |||
| Standard Deviation | 11.49 | |||
| Variance | 131.94 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for VistaGen Therapeutics
The number of cover stories for VistaGen Therapeutics depends on current market conditions and VistaGen Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that VistaGen Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about VistaGen Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
VistaGen Therapeutics Short Properties
VistaGen Therapeutics' future price predictability will typically decrease when VistaGen Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of VistaGen Therapeutics often depends not only on the future outlook of the potential VistaGen Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. VistaGen Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.7 M | |
| Cash And Short Term Investments | 80.5 M |
Check out Historical Fundamental Analysis of VistaGen Therapeutics to cross-verify your projections. To learn how to invest in VistaGen Stock, please use our How to Invest in VistaGen Therapeutics guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Biotechnology sector continue expanding? Could VistaGen diversify its offerings? Factors like these will boost the valuation of VistaGen Therapeutics. If investors know VistaGen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every VistaGen Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.92) | Revenue Per Share | Quarterly Revenue Growth 0.41 | Return On Assets | Return On Equity |
Investors evaluate VistaGen Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating VistaGen Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause VistaGen Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between VistaGen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VistaGen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, VistaGen Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.